AstraZeneca&#39;s Nexium Gets US Approval for New Use
79616
AstraZeneca Plc, the UK&#39;s second largest drugmaker, said US regulators approved its ulcer treatment Nexium for use in reducing the risk of stomach ulcers in patients taking certain painkillers
612544
Eli Lilly and Co. said on Tuesday that US regulators have approved its new antidepressant as a treatment for pain associated with nerve damage in diabetics
673366
Swiss pharmaceutical maker Novartis AG said yesterday it has received US approval for the hypertension drug Tekturna -- a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
643182
NEW YORK - Last night, the US Food and Drug Administration approved Tarceva, a pill that extends survival in advanced non-small-cell lung cancer patients for whom chemotherapy has failed.
258793
The US government approved a drug Tuesday to treat multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
142281
FDA advisory panel gives the nod to its heart drug.
407814
Shares in Irish drug group Elan Corp. PLC are expected to be in demand today, as investors react to news that Antegren, its multiple sclerosis (MS) drug now known as Tysabri, was granted accelerated approval by the US FDA last night.
318018
(WASHINGTON) - The maker of a new drug to treat women&#39;s sexual dysfunction says the product is safe and should be approved without delay.
112717
The US Food and Drug Administration Friday said it had approved Tarceva (erlotinib) tablets for patients with metastatic lung cancer.
127322
Swiss drug maker Novartis Pharma AG said Monday that the Food and Drug Administration approved another use for the company&#39;s Zelnorm irritable bowel drug, clearing Novartis to market the medicine as a treatment for chronic constipation in male and female
538105
Four months after an international panel of doctors recommended that the US Food and Drug Administration (FDA) approve InSightec&#39;s ExAblate 2000 for commercial use, the FDA announced on Friday that it had accepted the recommendation, and granted the
481177
Hostile environment prompts root and branch review. Exanta unlikely to win US approval in near future. By Stephen Foley. AstraZeneca, the UK&#39;s number two pharmaceuticals company, has launched a &quot;root and branch
512456
NEW YORK, September 9 (New Ratings) - The FDA has raised questions regarding AstraZenecaâs (AZN.NYS) blood thinner, Exanta. The leading pharmaceutical companyâs hopes had been pinned on Exanta, which
388799
The US Food and Drug Administration (FDA) has approved Sepracor Inc.&#39;s (Nasdaq: SEPR) Lunesta brand eszopiclone, a prescription non-benzodiazepine, for the long-term treatment of insomnia.
12817
A computer chip that is implanted under the skin won US approval on Wednesday for use in helping doctors quickly access a patient&#39;s medical history.
55400
The first implantable treatment to  prevent sleep apnea has received approval from U.S. regulators,  the company that developed the procedure said Tuesday.